Skip to main content
. 2015 Nov 9;68:29–41. doi: 10.1007/s00251-015-0880-z

Fig. 3.

Fig. 3

HLA-E-leader peptide complexes confer protection against NK cell mediated lysis. Cytotoxicity assay showing the percentage of lysed target cells. Depicted is the average of three independent experiments, shown FACS plots are exemplary. T2E*01:01 and T2E*01:03 cells were lysed in the absence of peptide. Top panel: T2E*01:01VMAPRTLVL showed decreased cytotoxicity (7.4 %) compared to T2E*01:01VMAPRTLFL (9.0 %), T2E*01:01VMAPRTLIL (8.3 %), or T2E*01:01VMAPRALLL (13.9 %). Bottom panel: T2E*01:03VMAPRTLFL showed decreased cytotoxicity (7.4 %) compared to T2E*01:03VMAPRTLVL (9.0 %), T2E*01:03VMAPRTLIL (8.3 %), or T2E*01:03VMAPRALLL (13.9 %). Overall cytotoxicity was decreased in T2E*01:03 in comparison to T2E*01:01